{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:10:01Z","timestamp":1789852201700,"version":"4.0.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Res"],"published-print":{"date-parts":[[2018]]},"DOI":"10.5045\/br.2018.53.2.169","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T04:47:04Z","timestamp":1530074824000},"page":"169","source":"Crossref","is-referenced-by-count":4,"title":["Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As\n                    <sub>2<\/sub>\n                    O\n                    <sub>3<\/sub>\n                    ) and all-trans retinoic acid (ATRA)"],"prefix":"10.1007","volume":"53","author":[{"given":"Preetesh","family":"Jain","sequence":"first","affiliation":[{"name":"Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergej","family":"Konoplev","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohad","family":"Benjamini","sequence":"additional","affiliation":[{"name":"Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Romagura","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Burger","sequence":"additional","affiliation":[{"name":"Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.5045\/br.2018.53.2.169_ref1","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.bbmt.2011.11.012","volume":"18","author":"Sehn","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.5045\/br.2018.53.2.169_ref2","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/leu.2012.57","volume":"26","author":"Mi","year":"2012","journal-title":"Leukemia"},{"key":"10.5045\/br.2018.53.2.169_ref3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/hon.870","volume":"27","author":"Chang","year":"2009","journal-title":"Hematol Oncol"},{"key":"10.5045\/br.2018.53.2.169_ref4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12032-015-0526-x","volume":"32","author":"Zhao","year":"2015","journal-title":"Med Oncol"},{"key":"10.5045\/br.2018.53.2.169_ref5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2174\/1871520611009060504","volume":"10","author":"Takahashi","year":"2010","journal-title":"Anticancer Agents Med Chem"},{"key":"10.5045\/br.2018.53.2.169_ref6","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1158\/1078-0432.CCR-06-1812","volume":"13","author":"Berenson","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.5045\/br.2018.53.2.169_ref7","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/annonc\/mdu142","volume":"25","author":"Gill","year":"2014","journal-title":"Ann Oncol"},{"key":"10.5045\/br.2018.53.2.169_ref8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00277-013-1866-2","volume":"93","author":"Lo","year":"2014","journal-title":"Ann Hematol"},{"key":"10.5045\/br.2018.53.2.169_ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10637-015-0301-z","volume":"34","author":"Yoon","year":"2016","journal-title":"Invest New Drugs"},{"key":"10.5045\/br.2018.53.2.169_ref10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0145-2126(01)00202-8","volume":"26","author":"Niitsu","year":"2002","journal-title":"Leuk Res"},{"key":"10.5045\/br.2018.53.2.169_ref11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2141.2010.08209.x","volume":"150","author":"Singh","year":"2010","journal-title":"Br J Haematol"},{"key":"10.5045\/br.2018.53.2.169_ref12","first-page":"4179","volume":"25","author":"Barna","year":"2005","journal-title":"Anticancer Res"}],"container-title":["Blood Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/synapse.koreamed.org\/pdf\/10.5045\/br.2018.53.2.169","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/synapse.koreamed.org\/DOIx.php?id=10.5045\/br.2018.53.2.169","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/synapse.koreamed.org\/DOIx.php?id=10.5045\/br.2018.53.2.169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T22:26:47Z","timestamp":1773354407000},"score":1,"resource":{"primary":{"URL":"https:\/\/synapse.koreamed.org\/DOIx.php?id=10.5045\/br.2018.53.2.169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5045\/br.2018.53.2.169","relation":{},"ISSN":["2287-979X","2288-0011"],"issn-type":[{"value":"2287-979X","type":"print"},{"value":"2288-0011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}